A Registry Study of Biomarkers in Mitral Valve Disease (BIOMS-MVD)

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Status: Enrolling

Conditions: Cardiovascular Diseases

Study type: Observational

Funder types: Other

Identifiers

NCT05141292

BIOMS-MVD

Details and patient eligibility

About

The registry study aims to discover the prognostic value of bio-markers in mitral valve disease

Full description

The purpose of this study is to investigate the prognostic value of biomarkers in mitral valve disease.Patients with confirmed diagnosis of mitral valve disease are enrolled.The primary outcome is all-cause mortality based on the death certificates. The secondary outcome is readmission for heart failure and all-cause mortality/readmission for heart failure according to the patients' medical records.

Enrollment: 5,000 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients clinically diagnosed with mitral valve disease in Beijing Anzhen Hospital from April 2016 to December 2019
• The operator performs more than 25 mitral valve operations per year / the operator unit has surgeons who complete 50 operations per year

Exclusion criteria

• Age ≤ 18 years
• Failure to obtain medical records and ultrasound data
• Refuse follow-up